CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 96 filers reported holding CYTOSORBENTS CORP in Q3 2021. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $169,000 | +19.9% | 40,437 | +132.2% | 0.00% | – |
| Q3 2021 | $141,000 | -78.0% | 17,413 | -79.5% | 0.00% | -100.0% |
| Q2 2021 | $641,000 | -38.8% | 84,927 | -29.7% | 0.00% | -50.0% |
| Q1 2021 | $1,048,000 | +7.4% | 120,786 | -1.3% | 0.00% | 0.0% |
| Q4 2020 | $976,000 | -5.2% | 122,424 | -5.1% | 0.00% | 0.0% |
| Q3 2020 | $1,029,000 | +1219.2% | 129,042 | +732.5% | 0.00% | – |
| Q3 2019 | $78,000 | -55.7% | 15,501 | -41.6% | 0.00% | – |
| Q2 2019 | $176,000 | -29.0% | 26,558 | -18.9% | 0.00% | – |
| Q1 2019 | $248,000 | -6.4% | 32,737 | 0.0% | 0.00% | – |
| Q4 2018 | $265,000 | -37.2% | 32,737 | 0.0% | 0.00% | – |
| Q3 2018 | $422,000 | +13.1% | 32,737 | 0.0% | 0.00% | – |
| Q2 2018 | $373,000 | +145.4% | 32,737 | +32.5% | 0.00% | – |
| Q2 2015 | $152,000 | – | 24,706 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 675,000 | $918,000 | 1.02% |
| Sargent Investment Group, LLC | 1,108,233 | $2,028,000 | 0.63% |
| Skylands Capital, LLC | 2,347,034 | $3,192,000 | 0.52% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 253,000 | $344,000 | 0.37% |
| Avenir Corp | 2,314,854 | $3,148,000 | 0.33% |
| Granahan Investment Management | 1,511,029 | $2,055,000 | 0.07% |
| ACT CAPITAL MANAGEMENT, LLC | 35,000 | $48,000 | 0.07% |
| Winning Points Advisors, LLC | 22,900 | $33,000 | 0.04% |
| Cowen Prime Advisors LLC | 42,200 | $57,000 | 0.03% |
| Seelaus Asset Management LLC | 23,900 | $33,000 | 0.03% |